These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 2981407)
21. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682 [TBL] [Abstract][Full Text] [Related]
22. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III). Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312 [TBL] [Abstract][Full Text] [Related]
23. HTLV and immunosuppression. Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649 [TBL] [Abstract][Full Text] [Related]
24. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Aiuti F; Rossi P; Sirianni MC; Carbonari M; Popovic M; Sarngadharan MG; Contu L; Moroni M; Romagnani S; Gallo RC Br Med J (Clin Res Ed); 1985 Jul; 291(6489):165-6. PubMed ID: 2990634 [TBL] [Abstract][Full Text] [Related]
25. LAV/HTLV-III neutralizing antibodies in the sera of patients with AIDS, lymphadenopathy syndrome and asymptomatic seropositive individuals. Faulkner-Valle GP; De Rossi A; Dalla Gassa O; Chieco-Bianchi L Tumori; 1986 Jun; 72(3):219-24. PubMed ID: 3016957 [TBL] [Abstract][Full Text] [Related]
26. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III). Hirsch MS; Wormser GP; Schooley RT; Ho DD; Felsenstein D; Hopkins CC; Joline C; Duncanson F; Sarngadharan MG; Saxinger C N Engl J Med; 1985 Jan; 312(1):1-4. PubMed ID: 2981106 [TBL] [Abstract][Full Text] [Related]
28. Serological characterization of HTLV-III infection in AIDS and related disorders. Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434 [TBL] [Abstract][Full Text] [Related]
29. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369 [TBL] [Abstract][Full Text] [Related]
30. Detection of anti-HTLV-III/LAV antibody by enzyme-linked immunosorbent assay in high-risk individuals in Switzerland 1974-1985. Stroun J; Graf I; Frei PC Eur J Clin Microbiol; 1985 Dec; 4(6):583-6. PubMed ID: 3004980 [TBL] [Abstract][Full Text] [Related]
31. HTLV-I-specific antibody in AIDS patients and others at risk. Robert-Guroff M; Blayney DW; Safai B; Lange M; Gelmann EP; Gutterman JW; Mansell PW; Goedert JL; Groopman JE; Steigbigel NH Lancet; 1984 Jul; 2(8395):128-31. PubMed ID: 6146035 [TBL] [Abstract][Full Text] [Related]
32. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546 [TBL] [Abstract][Full Text] [Related]
34. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS. Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034 [TBL] [Abstract][Full Text] [Related]
35. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Sarngadharan MG; Popovic M; Bruch L; Schüpbach J; Gallo RC Science; 1984 May; 224(4648):506-8. PubMed ID: 6324345 [TBL] [Abstract][Full Text] [Related]
37. AIDS serology testing in low- and high-risk groups. Carlson JR; Bryant ML; Hinrichs SH; Yamamoto JK; Levy NB; Yee J; Higgins J; Levine AM; Holland P; Gardner MB JAMA; 1985 Jun; 253(23):3405-8. PubMed ID: 2987558 [TBL] [Abstract][Full Text] [Related]
38. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Schüpbach J; Popovic M; Gilden RV; Gonda MA; Sarngadharan MG; Gallo RC Science; 1984 May; 224(4648):503-5. PubMed ID: 6200937 [TBL] [Abstract][Full Text] [Related]
39. Presence of antibodies to human lymphoma-leukemia virus (HTLV-I) in Germans with symptoms of the acquired immunodeficiency syndrome (AIDS). Born M; von der Helm K; Wernicke D; Deinhardt F J Med Virol; 1985 Jan; 15(1):57-63. PubMed ID: 2981978 [TBL] [Abstract][Full Text] [Related]
40. Detection of antibodies to HTLV-III by ELISA in AIDS risk groups in Taiwan: a preliminary report. Wang GR; Lin KT; Liu MF; Shieh CC; Shih LY; Lian DC; Lin TT; Chen CS; Chang SA Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):7-17. PubMed ID: 3469065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]